Sangamo Therapeutics Inc. (SGMO)

8.46
NASDAQ : Health Technology
Prev Close 8.46
Day Low/High 0.00 / 0.00
52 Wk Low/High 6.26 / 27.50
Avg Volume 1.86M
Exchange NASDAQ
Shares Outstanding 102.09M
Market Cap 890.25M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week of SGMO June 21st Options Trading

First Week of SGMO June 21st Options Trading

Investors in Sangamo BioSciences Inc saw new options become available this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGMO options chain for the new June 21st contracts and identified one put and one call contract of particular interest.

Relative Strength Alert For Sangamo BioSciences

Relative Strength Alert For Sangamo BioSciences

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insider Trading Alert - SPLK, SGMO And CMLP Traded By Insiders

Insider Trading Alert - SPLK, SGMO And CMLP Traded By Insiders

Stocks with insider trader activity include SPLK, SGMO and CMLP

SGMO Crosses Below Key Moving Average Level

SGMO Crosses Below Key Moving Average Level

In trading on Tuesday, shares of Sangamo BioSciences Inc crossed below their 200 day moving average of $13.57, changing hands as low as $13.04 per share. Sangamo BioSciences Inc shares are currently trading up about 0.4% on the day.

'Mad Money' Lightning Round: I Don't See a BioMarin Rally

'Mad Money' Lightning Round: I Don't See a BioMarin Rally

Cramer likes Service Corp. over Carriage Services and Magnum Hunter Resources over Swift Energy.

Jim Cramer's 'Mad Money' Recap: Blame China, Greece for the Meltdown

Jim Cramer's 'Mad Money' Recap: Blame China, Greece for the Meltdown

While everything went right in America, everything was going wrong in the rest of the world -- and that apparently makes all the difference, Cramer says.

Sangamo BioSciences (SGMO) Highlighted As Today's Perilous Reversal Stock

Sangamo BioSciences (SGMO) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a "perilous reversal" (up big yesterday but down big today) candidate

Heavy Volume And Pre-Market Movement For Sangamo BioSciences (SGMO)

Heavy Volume And Pre-Market Movement For Sangamo BioSciences (SGMO)

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a pre-market mover with heavy volume candidate

Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'

Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Watch These 3 High-Risk Stocks

Watch These 3 High-Risk Stocks

Chris Lau, Kapitall: These high-risk stocks have made big moves. Is it time for you to make a move? High-risk [...]

Jim Cramer: Happy Birthday, You Bogus Bull Market

Jim Cramer: Happy Birthday, You Bogus Bull Market

You've rallied 177%, yet many don't seem to believe you exist.

Jim Cramer's Top Stock Picks: TSLA SCTY SGMO CSX PF

Jim Cramer's Top Stock Picks: TSLA SCTY SGMO CSX PF

Sangamo BioSciences could one day cure a lot of diseases and Pinnacle Foods is one of Cramer's favorite food companies.

Jim Cramer's 'Mad Money' Recap: How to Value a Stock

Jim Cramer's 'Mad Money' Recap: How to Value a Stock

There are many ways to do so, and sticking to just one will cost you money, Cramer warns.

Let Price Action Be Your Guide

And stop looking for reasons not to like this market.

4 Huge Stocks on Traders' Radars

4 Huge Stocks on Traders' Radars

Here's a look at how to trade some of the most active stocks on the market today.

Heavy Early Morning Activity On Sangamo BioSciences (SGMO)

Heavy Early Morning Activity On Sangamo BioSciences (SGMO)

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a pre-market mover with heavy volume candidate

A Crazy and Unexpected Turnaround

Today's one-sided price action matched typical first-of-month mark-up behavior, suggesting the Ukraine crisis delayed that bullish event for one session.

Use Options For a Chance To Buy SGMO at a 58% Discount

Use Options For a Chance To Buy SGMO at a 58% Discount

Looking back to 162 days ago, Sangamo BioSciences Inc priced a 6,100,000 share secondary stock offering at $10.58 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Thursday, the stock is now 77.9% above the offering price.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron

The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron

Sangamo benefits from a Biogen partnership, but what does it mean for rivals Bluebird and Acceleron?

Use Options For a Chance To Buy SGMO at a 65% Discount

Use Options For a Chance To Buy SGMO at a 65% Discount

Looking back to 126 days ago, Sangamo BioSciences priced a 6,100,000 share secondary stock offering at $10.58 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday, the stock is now 82.9% higher than the offering price.

Jim Cramer's 'Mad Money' Recap: Buying Retail (Correct)

Jim Cramer's 'Mad Money' Recap: Buying Retail (Correct)

Questions on the continued strength of the consumer will be answered when Amazon reports, Cramer says.

'Mad Money' Lightning Round: Home Depot Beats Lowe's

'Mad Money' Lightning Round: Home Depot Beats Lowe's

Cramer says it's time to sell LSI but he likes Intersil and Exelixis.

Sangamo BioSciences (SGMO) In A Perilous Reversal

Sangamo BioSciences (SGMO) In A Perilous Reversal

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a "perilous reversal" (up big yesterday but down big today) candidate

22 Biotech Stock Predictions for 2014

22 Biotech Stock Predictions for 2014

TheStreet's Adam Feuerstein offers his biotech stock outlook for 2014 and grades his 2013 predictions.

Use Options For a Chance To Buy SGMO at a 52% Discount

Use Options For a Chance To Buy SGMO at a 52% Discount

Looking back to 97 days ago, Sangamo BioSciences priced a 6,100,000 share secondary stock offering at $10.58 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 29% higher than the offering price.

Interesting SGMO Put And Call Options For January 2016

Interesting SGMO Put And Call Options For January 2016

Investors in Sangamo BioSciences Inc saw new options become available today, for the January 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 772 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Use Options For a Chance To Buy SGMO at a 48% Discount

Use Options For a Chance To Buy SGMO at a 48% Discount

Looking back to 68 days ago, Sangamo BioSciences priced a 6,100,000 share secondary stock offering at $10.58 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 6.8% higher than the offering price.

SGMO Crosses Below Key Moving Average Level

SGMO Crosses Below Key Moving Average Level

In trading on Thursday, shares of Sangamo BioSciences Inc crossed below their 200 day moving average of $9.54, changing hands as low as $9.44 per share. Sangamo BioSciences Inc shares are currently trading off about 3.9% on the day.

TheStreet Quant Rating: D+ (Sell)